These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11266032

  • 1. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
    Kaplan LN, Mamer OA, Hoffer LJ.
    Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
    [Abstract] [Full Text] [Related]

  • 2. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.
    J Nephrol; 2003 Feb; 16(4):522-34. PubMed ID: 14696754
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME, Manns BJ, Snyder FF, Bridge PJ, Scott-Douglas NW, Fung E, Parsons HG.
    Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
    [Abstract] [Full Text] [Related]

  • 5. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE, Pérez Tamajón L, Hernández D, Alvarez González A, Delgado P, Lorenzo V.
    Nefrologia; 2005 Jun; 25(3):288-96. PubMed ID: 16053010
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
    Vrentzos GE, Papadakis JA, Vardakis KE, Maliaraki N, Stilianou K, Arvanitis A, Sratigis S, Alivanis P, Margioris AN, Ganotakis ES.
    J Nephrol; 2003 Jun; 16(4):535-9. PubMed ID: 14696755
    [Abstract] [Full Text] [Related]

  • 9. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India.
    Yajnik CS, Lubree HG, Thuse NV, Ramdas LV, Deshpande SS, Deshpande VU, Deshpande JA, Uradey BS, Ganpule AA, Naik SS, Joshi NP, Farrant H, Refsum H.
    Asia Pac J Clin Nutr; 2007 Jun; 16(1):103-9. PubMed ID: 17215186
    [Abstract] [Full Text] [Related]

  • 10. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R, Bonnardeaux A, Geadah D, Busque L, Lebrun M, Ouimet D, Leblanc M.
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [Abstract] [Full Text] [Related]

  • 11. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
    Taes YE, Delanghe JR, De Bacquer D, Langlois M, Stevens L, Geerolf I, Lameire NH, De Vriese AS.
    Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [Abstract] [Full Text] [Related]

  • 13. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E, Pérez Melón C, Otero A, Gayoso P, Rodríguez M, Esteban Morcillo J.
    Nefrologia; 2001 Sep; 21(2):167-73. PubMed ID: 11464650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Selhub J.
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [Abstract] [Full Text] [Related]

  • 17. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
    Dierkes J, Domröse U, Ambrosch A, Schneede J, Guttormsen AB, Neumann KH, Luley C.
    Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
    [Abstract] [Full Text] [Related]

  • 18. Cobalamin dose regimen for maximum homocysteine reduction in end-stage renal disease.
    Hoffer LJ, Saboohi F, Golden M, Barré PE.
    Metabolism; 2005 Jun; 54(6):835-40. PubMed ID: 15931623
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F, Abassi Z, Plawner M, Khankin E, Ramadan R, Lanir N, Brenner B, Green J.
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.